.
Covid-19 Developments and Predictions, Effects on Humans and Humanity Itself
Study Course Description
Course Description Statuss:Approved
Course Description Version:2.00
Study Course Accepted:18.08.2021 13:44:55
| Study Course Information | |||||||||
| Course Code: | IUDK_035 | LQF level: | Level 7 | ||||||
| Credit Points: | 2.00 | ECTS: | 3.00 | ||||||
| Branch of Science: | Clinical Medicine; Infectious Diseases | Target Audience: | Medicine | ||||||
| Study Course Supervisor | |||||||||
| Course Supervisor: | Ludmila Vīksna | ||||||||
| Study Course Implementer | |||||||||
| Structural Unit: | Department of Infectology | ||||||||
| The Head of Structural Unit: | |||||||||
| Contacts: | Riga, 3 Linezera Street, idk rsu[pnkts]lv, +371 67014777 | ||||||||
| Study Course Planning | |||||||||
| Full-Time - Semester No.1 | |||||||||
| Lectures (count) | 0 | Lecture Length (academic hours) | 0 | Total Contact Hours of Lectures | 0 | ||||
| Classes (count) | 8 | Class Length (academic hours) | 4 | Total Contact Hours of Classes | 32 | ||||
| Total Contact Hours | 32 | ||||||||
| Study course description | |||||||||
| Preliminary Knowledge: | Anatomy, biochemistry, biology, microbiology, pathological physiology, propaedeutics, immunology, oral diseases, radiology, pharmacology, epidemiology, laboratory medicine. | ||||||||
| Objective: | The aim of the study course is to promote expanded theoretical and practical knowledge in the context of viral infections, to understand theoretical and practical deviations from stereotypical disease standards, pathogenetic variations, micro- and macro-organism relationships and impact options, approaches to modern epidemic patterns, unique methods of prevention. Transmission of SARS-CoV-2 from the animal environment to the human population and its associated global health implications. | ||||||||
| Topic Layout (Full-Time) | |||||||||
| No. | Topic | Type of Implementation | Number | Venue | |||||
| 1 | Possibilities, variants, consequences and effects of transmission of animal infections to humans. Preconditions for the transfer of pathogens from one species to another. | Classes | 1.00 | clinical base | |||||
| 2 | Acute SARS-CoV-2 infection: etiology, diagnosis, pathogenesis. | Classes | 1.00 | clinical base | |||||
| 3 | Covid-19: clinical manifestations, radiological characteristics, laboratory criteria. | Classes | 1.00 | clinical base | |||||
| 4 | Covid-19: risk groups, approaches to therapy, prognosis. | Classes | 1.00 | clinical base | |||||
| 5 | Covid-19: principles of patient monitoring, approaches to intensive care. | Classes | 1.00 | clinical base | |||||
| 6 | Covid-19: characterization of the disease in the cardiovascular system, urinary, endocrine and hepatobiliary systems. | Classes | 1.00 | clinical base | |||||
| 7 | Covid-19 and CNS. | Classes | 1.00 | clinical base | |||||
| 8 | Covid-19: sequelae, rehabilitation, disability, prevention. | Classes | 1.00 | clinical base | |||||
| Assessment | |||||||||
| Unaided Work: | Preliminary preparation for the lesson topic, Individual Study Report. | ||||||||
| Assessment Criteria: | Practical class attendance and evaluation of Individual Study Report - 50%, a theoretical question - 50% | ||||||||
| Final Examination (Full-Time): | Exam | ||||||||
| Final Examination (Part-Time): | |||||||||
| Learning Outcomes | |||||||||
| Knowledge: | Students will be able to describe the future possibilities of infections and infectious diseases, knowing the factors of natural and technological influence, possible directions of pathogenesis, the possibility to develop in the changed external environment, the impact on the individual and public health; describe and identify the specific stages of infection development; explain the causes of globalization of infections and systematize methods; formulate and explain the principles of future therapy; link the stages of the health plan to individualized health care, especially in the case of chronic infections; will explain the principles of future specific prevention, applying them to both society and the individual. | ||||||||
| Skills: | Students will be able to create a draft plan for medical activities aimed at diagnosing and treatment an individual's disease; will be able to analyze the drawn up plan, taking into account the presence or absence of laboratory tests and other data; will be able to evaluate other types of data obtained as a result of investigations; will be able to integrate all types of examinations into the diagnostic design of an infectious disease; to plan the measures necessary to limit the spread of the infection. | ||||||||
| Competencies: | Students will be able to apply basic knowledge of argumentation, logic and rhetoric to analyze situations in practical infectology and situations in theoretical infectology, discuss, explain one's opinion and constructively promote the achievement of professional goals and specific tasks in ensuring individual and public health; in the face of non-standard situations, to successfully communicate in the fields of prevention, diagnosis, differential diagnosis and treatment of infectious diseases; to cooperate professionally with patients, patients' relatives, colleagues in an atmosphere of dignity, observing the norms of medical ethics, respecting the rights of patients and ensuring epidemiological safety; to independently learn and use the e-medicine environment for communication with students and colleagues; to demonstrate and improve oneself as a future medical practitioner and health promoter in the context of specific and non-specific prevention of infectious diseases. | ||||||||
| Bibliography | |||||||||
| No. | Reference | ||||||||
| Required Reading | |||||||||
| 1 | Rekomendācijas par SARS-CoV-2 infekcijas un COVID-19 epidemioloģiju, diagnostiku, klīniskajām norisēm un komplikācijām. Valsts pētījumu programma. L.Vīksna, I.Tolmane un autoru kolektīvs. Rīga, 2021. gada marts. 227 lpp. (latviešu plūsmai) | ||||||||
| 2 | Coronoviruses deseases 2019-(COVID-19) treatment quidelines – www.covid19treatment.nih.gov- National Institute of Health – update June 17 2021 | ||||||||
| 3 | https://covid19.who.int/ | ||||||||
| 4 | https://www.cdc.gov/ | ||||||||
| 5 | https://www.medscape.com/resource/coronavirus | ||||||||
| Additional Reading | |||||||||
| 1 | https://www.who.int/emergencies/diseases/novel-coronavirus-… | ||||||||
| 2 | https://covid19.who.int/region/euro/country/lv | ||||||||
| 3 | https://www.who.int/emergencies/diseases/novel-coronavirus-… | ||||||||
| 4 | https://www.cdc.gov/coronavirus/2019-ncov/index.html | ||||||||
| 5 | https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidv… | ||||||||
| 6 | https://www.medscape.com/resource/uk-coronavirus | ||||||||
| 7 | https://www.spkc.gov.lv/lv/arstiem-par-covid-19-infekcijas-… (latviešu plūsmai) | ||||||||
| 8 | https://www.ecdc.europa.eu/en/covid-19 | ||||||||
| 9 | World Health Organization. Interim Guidance on Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected external icon.https://www.who.int/publications/i/item/WHO-2019-nCoV-clini… | ||||||||
| 10 | National Institutes of Health. Coronavirus Disease 2019 (COVID-19) Treatment Guidelineshttps://www.covid19treatmentguidelines.nih.gov/ | ||||||||
| 11 | COVID-19 rapid guideline: managing the long-term effects of COVID-19 NICE guideline [NG188]Published: 18 December 2020https://www.nice.org.uk/guidance/NG188 | ||||||||
| 12 | Ceters for Disease Control and Prevention.2019 Novel coronavirus, Wuhan, China. Infomation for Healthcare Professionals. https://www.cdc.gov/coronavirus/2019-ncov/hcp/index.html | ||||||||
| 13 | NICE guideline on long COVID https://www.thelancet.com/article/S2213-2600(21)00031-X/ful… | ||||||||
| Other Information Sources | |||||||||
| 1 | https://www.gisaid.org/hcov19-variants/ | ||||||||
| 2 | https://www.ema.europa.eu/en/human-regulatory/overview/publ… | ||||||||
| 3 | https://www.zva.gov.lv/lv/pacientiem-un-sabiedribai/zales/c… (latviešu plūsmai) | ||||||||
